Implantable Cardioverter‐Defibrillator Programming: It Is Time to Get Things Right With a Checklist Manifesto

Implantable Cardioverter‐Defibrillator Programming: It Is Time to Get Things Right With a Checklist Manifesto

Saved in:

Bibliographic Details
Main Authors:	Salvatore Savona, Raul Weiss
Format:	Article
Language:	English
Published:	Wiley 2024-08-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	Editorials ICD programming Innapropriate shocks registries
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.124.036211
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry
by: Nikias Milaras, et al.
Published: (2025-06-01)

Impact of Sudden Cardiac Arrest and Implantable Cardiac Defibrillator Shocks on Mental Health
by: Estelle Torbey, MD, et al.
Published: (2025-06-01)

Biotronik Implantable Cardioverter Defibrillator for Measurement of Intrathoracic Impedance: A Report of Two Cases
by: Xuqing Ying, et al.
Published: (2024-11-01)

Benefit of implantable cardioverter defibrillator use in Japanese patients based on modified MADIT‐ICD benefit score
by: Toshinori Chiba, et al.
Published: (2025-02-01)

Nutritional Status Is Associated with Mortality but Not Appropriate Discharge of Implantable Cardioverter Defibrillators in Patients with Heart Failure
by: Idris Yakut, et al.
Published: (2025-03-01)

Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators
by: Carmelo La Greca, et al.
Published: (2025-08-01)

Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation
by: T. O. Bessonova, et al.
Published: (2022-04-01)

Phoenix from the Ashes: An Advocacy for an International Consensus for Return To Play for Athletes with Implantable Cardioverter Defibrillators
by: Andreas Müssigbrodt
Published: (2025-07-01)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)

Association of Frailty With Clinical Outcomes in Patients Receiving Primary Prevention Implantable Cardioverter Defibrillators: A Prospective Cohort Study
by: Dmitry Neymark, et al.
Published: (2025-03-01)

Thrombosis of the superior vena cava in a patient with an implanted cardioverter–defibrillator: A case report
by: Elena V. Paranina, et al.
Published: (2024-11-01)

Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator
by: Celestino Sardu, et al.
Published: (2025-06-01)

Implantable cardioverter defibrillator: decision-making on turning off in patients with end-stage heart failure
by: V. K. Lebedeva, et al.
Published: (2020-09-01)

Predictors of Shock‐Reduction Programming and Its Impact on Implantable Cardioverter‐Defibrillator Therapies and Mortality: The CERTITUDE Registry
by: Sebastian E. Beyer, et al.
Published: (2024-08-01)

Analysis of arrhythmic episodes in patients with implanted cardioverter defibrillators and a high risk of sudden cardiac death
by: A. S. Postol, et al.
Published: (2019-11-01)

Survival benefit of primary prevention implantable cardioverter‐defibrillator/cardiac resynchronization therapy with a defibrillator: Analysis of the Japan cardiac device treatment registry and Japanese cardiac registry of heart failure in cardiology
by: Hisashi Yokoshiki, et al.
Published: (2025-06-01)

Improved outcomes of cardiac resynchronization therapy with a defibrillator in systolic heart failure: Analysis of the Japan cardiac device treatment registry database
by: Hisashi Yokoshiki, et al.
Published: (2024-02-01)

Return‐to‐play in athletes with transvenous and subcutaneous implantable cardiac defibrillator: A meta‐analysis
by: Rifqi Rizkani Eri, et al.
Published: (2025-08-01)

Battery Longevity in Modern Implantable Cardioverter‐Defibrillators and Cardiac Resynchronization Therapy‐Defibrillators
by: Kotaro Nishino, et al.
Published: (2025-08-01)

How to Indicate Implantable Cardioverter‐Defibrillator in Patients With Malignancy
by: Naoya Kataoka, et al.
Published: (2025-08-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

How to indicate implantable cardioverter‐defibrillator in the aging population
by: Risako Orita, et al.
Published: (2025-04-01)

Appropriate implantable cardioverter-defibrillator therapy triggered by heat stroke
by: Carlos Fernando Paz Mamani, et al.
Published: (2025-01-01)

Customizing solutions: Ventricular tachycardia and implantable cardioverter-defibrillator programming
by: Tatiana Pavlenko, et al.
Published: (2024-12-01)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
by: Hirota Kida, et al.
Published: (2025-06-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

URGENT CATHETER ABLATION OF THE ELECTRICAL STORM IN PATIENTS WITH IMPLANTED CARDIOVERTER-DEFIBRILLATOR
by: R. B. Tatarsky, et al.
Published: (2015-11-01)

Relapsed Brucellosis Manifested as Endocarditis with Vegetation on the Implantable Cardioverter Defibrillator Lead
by: Bisher Sawaf, et al.
Published: (2021-01-01)

Depression and Implantable Cardioverter‐Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death
by: Brian C. Boursiquot, et al.
Published: (2024-07-01)

A new approach in cardioverter-defibrillator implantation in patients with coronary artery disease
by: Т. A. Atabekov, et al.
Published: (2019-04-01)

Perioperative Management of Pacemakers (PM) and Implantable Cardioverter Defibrillators (ICD) in South Africa
by: A. Keene
Published: (2019-04-01)

Life-Threatening Coronary Vasospasm Treated by Implantable Cardioverter Defibrillator: The Warning Signs
by: Deborah Adepoju, et al.
Published: (2022-01-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy
by: Mohammad Taghi Hedayati Goudarzi, et al.
Published: (2023-01-01)

First Reported Case of Candida dubliniensis Endocarditis Related to Implantable Cardioverter-Defibrillator
by: Nooraldin Merza, et al.
Published: (2020-01-01)

Modified procedures of subcutaneous implantable cardioverter defibrillator implantation for a child with small body size
by: Satoshi Oka, et al.
Published: (2024-02-01)

Social Determinants of Health‐Related Outcomes in an Intervention Following Initial Implantable Cardioverter‐Defibrillator Implantation
by: Megan M. Streur, et al.
Published: (2025-05-01)

Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)

Serratia marcescens: A Rare Cause of Recurrent Implantable Cardioverter Defibrillator Site Infection
by: S. Hawkey, et al.
Published: (2015-01-01)